VANFLYTA 17.7 mg, Filmtabletten - 14 Swissmedic Key 69710001 Registration Holder Daiichi Sankyo (Schweiz) AG Name VANFLYTA 17.7 mg, Filmtabletten Date of registration 31.03.2025 Introduction of Sequence 31.03.2025 ATC-Classification Quizartinib (L01EX11) Revision date WHO WHO-DDD Valid until 30.03.2030 Index Therapeuticus (BSV) Show package size 14 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680697100011 Medication Code Synthetika Pharmacode Disponibility
Composition quizartinibi dihydrochloridum 20 mg corresp. quizartinibum 17.7 mg, hydroxypropylbetadexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, talcum, triacetinum, E 171, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Quizartinibi Dihydrochloridum 20 mg correspond Quizartinibum 17.7 mg
Inactive agents additional_information Cellulosum Microcristallinum E 171 color. Hydroxypropylbetadexum Hypromellosum Überzug Magnesii Stearas Pro Compresso Obducto Talcum Triacetinum
Source Data was imported : 04.04.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
